Arrowhead Pharmaceuticals clarifies shares outstanding as of February 1, 2023

ARROWHEAD PHARMACEUTICALS, INC.

Filed an 8-K on February 7, 2023 to clarify that shares outstanding as of February 1, 2023 were 106,710,568.
The clarification follows the filing of the quarterly report on Form 10-Q for the first quarter of fiscal 2023 on February 6.
The company's common stock is listed on Nasdaq under ticker ARWR.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.